Here is a consolidated review of the most prominent insider stock sales disclosed on Friday for companies listed in the United States. The filings and accompanying data outline multiple sizable dispositions by senior executives and directors, most conducted under pre-established trading arrangements.
CoreWeave - senior executives sold large blocks
CoreWeave, Inc. reported two material insider sales across April 1 and April 2, 2026. Brian M. Venturo, the company’s Chief Strategy Officer, disposed of Class A Common Stock totaling $111.6 million. The sales were executed under a 10b5-1 trading plan and occurred in multiple transactions with trade prices ranging from $77.4269 to $81.2986 per share. The April 1 transactions included shares held indirectly through West Clay Capital LLC, the Venturo Family GST Exempt Trust dated June 30, 2023, YOLO ECV Trust and YOLO APV Trust.
Also at CoreWeave, Chief Executive Officer and President Michael N. Intrator - who is listed as a director and a 10% owner - sold 418,722 shares of Class A Common Stock on April 1, 2026, for aggregate proceeds of approximately $34.9 million. Those shares were sold at prices ranging from $77.4778 to $80.164 per share. The Intrator transactions were executed pursuant to a Rule 10b5-1 trading plan that the company disclosed was adopted on November 20, 2025.
The filings note that CoreWeave shares have returned roughly 72% over the past 12 months and that the stock had a 52-week high of $187, leaving the share price down 56% from that peak. Over the most recent week reported, the stock rose by about 9.9%. An InvestingPro analysis included with the disclosure highlights the company’s significant debt load and rapid cash burn as financial characteristics investors should consider alongside the insider sales.
Astera Labs - director exits shares under pre-arranged plan
Astera Labs, Inc. disclosed that Director Manuel Alba sold 183,730 shares of common stock on April 1, 2026, under a pre-arranged 10b5-1 trading plan, according to the Form 4 filing. The total proceeds from those sales were approximately $19.7 million. The transactions occurred in several blocks, with weighted average prices that include $106.3194 for 57,001 shares, $107.4443 for 24,317 shares, $108.3324 for 45,668 shares, $109.1027 for 15,367 shares, $110.2112 for 5,060 shares, and $111.1412 for 2,587 shares. A separate block of 33,000 shares was sold at an average price of $107.6141.
The timing of Mr. Alba’s sales coincides with significant recent volatility for Astera Labs: the stock is reported to have declined 42% over the past six months while it has registered an approximately 110% gain over the last year. An InvestingPro note cited alongside the filing characterizes Astera Labs’ share-price movements as quite volatile.
Apple - CEO sales under existing plan
Apple Inc. disclosed that Chief Executive Officer Timothy D. Cook sold company stock totaling $16.5 million on April 2, 2026. The sales were completed across multiple transactions at prices between $251.25 and $256.00 per share. The Form 4 filing itemizes the blocks: 5,087 shares at $251.25; 9,147 shares at $252.11; 1,878 shares at $253.13; 16,083 shares at $254.37; 28,188 shares at $255.17; and 4,566 shares at $256.00. These sales were carried out under a Rule 10b5-1 trading plan that Mr. Cook adopted on May 24, 2024.
At the time of the disclosure, Apple’s share price was reported at $255.92 and the company’s market capitalization was cited as $3.76 trillion. An InvestingPro assessment noted that Apple appears overvalued relative to its Fair Value and placed the company on a Most Overvalued list, while also assigning a financial health score described as "GOOD" and reporting an elevated price-to-earnings ratio of 32.38.
Micron - executive sale of 40,000 shares
Micron Technology Inc. reported that Executive Vice President and Chief People Officer April Arnzen sold 40,000 shares of common stock on April 1, 2026, with total proceeds of $13,895,761, according to a Form 4 filed with the SEC. The company’s reported share price at the time of filing was $366.24, and its market capitalization was given as $413 billion.
The Form 4 details multiple sale blocks by Ms. Arnzen. Specifically, 8,630 shares were sold at prices in the $344.722 to $345.7108 range for aggregate proceeds of $2,988,423. A further 5,766 shares were sold in the $345.7221 to $346.71 range for total proceeds of $1,996,393. There were 604 shares sold at prices between $346.72 and $346.90 for $209,495. The largest tranche consisted of 25,000 shares sold at $348.46 per share for proceeds of $8,711,500.
According to the filing, Micron’s shares have climbed nearly 394% over the past year. An InvestingPro analysis referenced with the disclosure states that the stock remains undervalued relative to its Fair Value.
Context on interpreting insider transactions
The recent filings illustrate a pattern of notable insider dispositions among executives and directors across companies in the technology and semiconductor sectors. All of the CoreWeave and Astera Labs transactions were executed under pre-arranged 10b5-1 trading plans, and the CoreWeave and Apple sales reference Rule 10b5-1 arrangements adopted on specified prior dates.
Investors frequently monitor insider activity as one input when assessing company prospects. The filings and accompanying analyst commentary included with these disclosures underscore that insider sales can occur for a variety of non-operational reasons, such as personal financial planning, tax obligations or portfolio diversification. Conversely, some investors view sizeable insider purchases as potential signals of executive confidence in future company performance. The filings do not establish the motives for these sales, and the documents and analyst notes cited here stop short of linking the transactions to specific future company outcomes.
Given the information presented in the filings - which include precise dates, share counts, price ranges, and references to trading-plan adoption dates - market participants are able to consider these transactions alongside other financial metrics, company fundamentals and market conditions when making investment decisions. The investor-facing commentary explicitly advises that insider transactions represent one facet of analysis and that context and patterns over time are important when interpreting their significance.
Bottom line
The Form 4 filings made public on Friday document significant insider sales at CoreWeave, Astera Labs, Apple and Micron, with detailed breakdowns of share counts, prices and trading-plan status. The disclosures are accompanied by analyst notes highlighting issues such as CoreWeave’s debt levels and cash burn, Astera Labs’ pronounced price volatility, Apple’s elevated valuation metrics, and Micron’s strong one-year price appreciation paired with a cited undervaluation relative to its Fair Value. Investors should weigh these factual disclosures together with broader financial analysis when assessing any implications.